China News Service, September 16 (Chen Jing Jiang Rong) Since the 1990s, American medical expert Professor Pei Zhengkang has traveled to China and the United States to help the development of the Chinese childhood leukemia profession.
He instructed Chinese medical institutions to complete the entire medical cost and analysis study of childhood acute lymphoblastic leukemia (hereinafter referred to as "ALL"), and raised 15 million yuan from overseas to help children in China... This American professor of pediatrics 16 Received the 2020 Shanghai Magnolia Memorial Award
The "White Magnolia Memorial Award" is a foreign commendation award established by Shanghai. It is awarded once a year to encourage and commend foreigners who have made outstanding contributions to Shanghai's economic construction, social development and foreign exchanges.
Pei Zhengkang was awarded the 2020 Shanghai Magnolia Memorial Award.
Photo courtesy of Shanghai Children's Medical Center
As the director of the oncology department of the St. Sude Children’s Research Hospital in the United States, Pei Zhengkang is a world-renowned expert and has made outstanding contributions to improving the cure rate of leukemia.
His clinical research results have made the cure rate of ALL more than 90%; he proposed and demonstrated the treatment method to protect children with ALL from head radiotherapy and avoid related complications.
In 2015, Pei Zhengkang was elected as a foreign academician of the Chinese Academy of Engineering. He is also the chief consultant of the Child Leukemia Expert Committee of the National Health Commission.
It is reported that in the 1990s, the overall five-year survival rate of children with ALL in Shanghai was about 62%, compared with 87.8% in the United States, which is a large gap.
Since then, Pei Zhengkang has been rushing back and forth between China and the United States to help the development of the Chinese childhood leukemia profession.
Today, the cure rate of childhood leukemia in China has reached the international advanced level and has become one of the models in the diagnosis and treatment of malignant diseases.
It is understood that shortly after the opening of the Shanghai Children’s Medical Center, Pei Zhengkang organized the donation of the most advanced flow cytometer in the world at that time for the diagnosis of leukemia immunotyping. For more than 20 years, Professor Pei Zhengkang and his team have contributed to China More than 100 professional medical staff provided short-term training.
Since 2005, Professor Pei Zhengkang has worked with Chinese experts to create and improve the classic treatment plan for children with ALL.
As a doctor, Pei Zhengkang has a benevolent heart.
In 2004, Professor Pei Zhengkang saw a poor mother cry because she could not afford to treat her child for leukemia.
He realized that the continuous improvement of the treatment plan has made the survival rate of children continue to increase, but for poor families, treatment is still a great economic burden.
Back in the United States, Professor Pei Zhengkang immediately began to raise funds to help children with leukemia from poor Chinese families.
It is reported that up to now, the American doctor has raised 15 million yuan (the same below) from overseas to provide free treatment and partial life support for 84 ALL children.
As the chief consultant of the Hematology Oncology Center of Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University School of Medicine, Pei Zhengkang also guided Shanghai Children's Medical Center to complete the entire medical cost and analysis study of children's ALL.
The research results provided an important reference for the Chinese government's introduction and implementation of the "New Rural Cooperative Medical Insurance" policy for childhood leukemia in 2009.
It is reported that after the implementation of relevant policies, the actual reimbursement rate of poor children with leukemia has increased to more than 80%.
In recent years, Professor Pei Zhengkang has focused more on the Chinese pediatrics system and international emerging scientific research.
As the director of the International Expert Advisory Committee of the National Children's Medical Center and one of the important top designers, he is very concerned about the development of Shanghai's construction of a first-class medical center city in Asia and the innovative development of children's hematology and tumor biomedicine in Zhangjiang National Science and Technology City.
(Finish)